Other indications (e.g. myeloproliferative diseases), Myelodysplastic Syndrome (MDS)
other systemic therapies
Longitudinal, App-based Assessment of Varying Red Blood Cell Transfusion Strategies and their Association with Patient-Reported and Clinical Outcomes in Lower-Risk MDS Patients
Longitudinal, App-based Assessment of Varying Red Blood Cell Transfusion Strategies and their Association with Patient-Reported and Clinical Outcomes in Lower-Risk MDS Patients
